The National University Health System is a group of healthcare institutions in Singapore. The group was formed in 2008 and operates several hospitals, national specialty centres, and polyclinics. The National University Hospital is the largest hospital in the group and serves as the flagship hospital for the cluster.

During the past decade, National University Health System conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National University Health System" #1 sponsor was "National University Hospital, Singapore" with 11 trials, followed by "National University of Singapore" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "National University Health System, Singapore" with 2 trials sponsored and "St. Jude Children's Research Hospital" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National University Health System" #1 collaborator was "Genzyme, a Sanofi Company" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 1 trials as a collaborator and "National University of Singapore" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National University Health System" are "Postoperative Delirium" (2 trials), "ARDS" (1 trials), "Acute Kidney Injury" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Adult Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "National University Health System" in a lesser frequency.

Most popular intervention types in "National University Health System" are "Drug" (6 trials), "Other" (6 trials), "Device" (5 trials), "Diagnostic Test" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Adult esophageal balloon catheter (obc)" (1 trials), "COP, COPADM8, CYVE" (1 trials), "COP, COPD M3, CYM" (1 trials), "COPAD" (1 trials) and "CliniMACS" (1 trials). Other intervention names were less common.

The vast majority of trials in "National University Health System" are 21 trials for "All" genders.

Currently, there are NaN active trials in "National University Health System". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in National University Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National University Health System, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

National University Health System has several departments that took part in Clinical trials: "Investigational Medicine Unit, National University Health System" - 2 trials